MoneyWorks4Me

Mercury Laboratories - Quaterly Results

13 Aug 2025 Evaluate
The Revenue for the quarter ended  June 2025 of Rs. 181.35 millions grew by 8.74 % from Rs. 166.77 millions.Net Profit witnessed a 182.75% growth almost the double from Rs. 3.42 millions to Rs. 9.67  millions  of same quarter last year.The company reported a good operating profit of 25.35 millions compared to 17.56 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 181.35 166.77 8.74 181.35 166.77 8.74 751.01 755.59 -0.61
Other Income 1.81 1.50 20.67 1.81 1.50 20.67 10.69 10.88 -1.75
PBIDT 25.35 17.56 44.36 25.35 17.56 44.36 80.85 101.20 -20.11
Interest 1.45 1.38 5.07 1.45 1.38 5.07 5.48 3.83 43.08
PBDT 23.90 16.18 47.71 23.90 16.18 47.71 75.37 97.37 -22.59
Depreciation 8.43 6.98 20.77 8.43 6.98 20.77 28.76 28.16 2.13
PBT 15.47 9.20 68.15 15.47 9.20 68.15 46.61 69.21 -32.65
TAX 5.80 5.78 0.35 5.80 5.78 0.35 15.16 12.66 19.75
Deferred Tax 1.00 1.78 -43.82 1.00 1.78 -43.82 1.68 -6.34 -126.50
PAT 9.67 3.42 182.75 9.67 3.42 182.75 31.45 56.55 -44.39
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 13.98 10.53 32.76 13.98 10.53 32.76 10.77 13.39 -19.62
Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1243.65
Cipla 1386.75
Lupin 2083.15
Zydus Lifesciences 1213.55
View more..